Sovaldi and Harvoni Approved for Pediatric Patients
Drug Alerts , News / April 15, 2017

The FDA approved supplemental applications for Sovaldi (sofosbuvir) and Harvoni (ledipasvir and sofosbuvir) to treat hepatitis C virus (HCV) in children ages 12 to 17. Harvoni and Sovaldi were previously approved to treat HCV in adults. These are ...

Skip to toolbar